These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32240674)

  • 1. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An expanding world of new psychoactive substances-designer benzodiazepines.
    Zawilska JB; Wojcieszak J
    Neurotoxicology; 2019 Jul; 73():8-16. PubMed ID: 30802466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal identification in addictovigilance: the functioning of the French system.
    Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A
    Therapie; 2015; 70(2):113-31. PubMed ID: 25858567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health consequences of cocaine use in France: data from the French Addictovigilance Network.
    Eiden C; Vincent M; Serrand C; Serre A; Richard N; Picot MC; Frauger E; Fouilhé N; Daveluy A; Peyrière H;
    Fundam Clin Pharmacol; 2021 Apr; 35(2):455-465. PubMed ID: 32854152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement of addictovigilance in emergency department for the detection of abuse and dependence cases: 3 years of experience].
    Serre A; Eiden C; Gourhant V; Laureau M; Perier D; Giraud I; Sebbane M; Peyrière H
    Therapie; 2018 Dec; 73(6):501-509. PubMed ID: 30017376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study.
    Jouanjus E; Falcou A; Deheul S; Roussin A; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1286-1292. PubMed ID: 30255533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death cases involving certain new psychoactive substances: A review of the literature.
    Kraemer M; Boehmer A; Madea B; Maas A
    Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cathinones use in Paris].
    Batisse A; Grégoire M; Marillier M; Fortias M; Djezzar S
    Encephale; 2016 Aug; 42(4):354-60. PubMed ID: 26847479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
    Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J
    Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cathinones: a new public health problem.
    Karila L; Megarbane B; Cottencin O; Lejoyeux M
    Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)].
    Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP
    Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].
    Batisse A; Peyrière H; Eiden C; Courné MA; Djezzar S;
    Therapie; 2016 Oct; 71(5):447-455. PubMed ID: 27203172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution.
    Dupui M; Micallef J; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network.
    Eiden C; Leone-Burgos S; Serre A; Carton L; Gerardin M; Le Boisselier R; Gibaja V; Monzon E; Fouilhe N; Boucher A; Peyriere H;
    Fundam Clin Pharmacol; 2018 Dec; 32(6):654-662. PubMed ID: 29956843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
    Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.